Description
The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) | HTML | Open resource |